Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 18, 2010

Lonza and CPRI Ally on Peptide Manufacturing and Development Services

  • Lonza and California Peptide Research (CPRI) are joining forces to more effectively serve customers requesting peptide manufacturing and development services. CPRI’s high-quality small-scale services will complement Lonza's capabilities in custom cGMP peptide manufacturing and development.

    The alliance aims at providing customers with a more complete offering that spans research through to commercial supply. It will also enable a seamless transition of custom peptide projects between CPRI’s small-scale facility and Lonza’s cGMP facilities.

    Based in San Franciscon, CPRI's customer base in North America will add to Lonza's existing facilities in Braine-l'Alleud (Belgium), Visp (Switzerland), Nansha (China), and Kourim (Czech Republic).



Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »